Patent Assignment
Reel/Frame 013206/0406
Assignment of Assignor's Interest
Recorded: 2002-08-20
Pages: 4
Assignors
JACKOWSKI, GEORGE
Executed: 2002-03-13
THATCHER, BRAD
Executed: 2002-03-13
STANTON, ERIC B.
Executed: 2002-03-21
VREES, TAMMY
Executed: 2002-03-14
YANTHA, JASON
Executed: 2002-03-13
MARSHALL, JOHN
Executed: 2002-03-12
Assignee
SYN X PHARMA
6354 VISCOUNT ROAD, MISSISSAUGA, ONTARIO L4V 1H3, CANADA
Covered Property
(1)
Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons
Application:
09/845,726 →
Publication:
US 2002/0160417
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 10, 2002
From: JACKOWSKI, GEORGE; THATCHER, BRAD; MARSHALL, JOHN; YANTHA, JASON
To: SYN X PHARMA
Reel/Frame 012816/0777 →
Security Agreement
Jul 18, 2003
From: SYNX PHARMA INC.
To: CANADA TRUST COMPANY, THE
Reel/Frame 014242/0790 →
Security Interest
Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
Change of Name
Jul 5, 2006
From: SYN X PHARMA INC.
To: NANOGEN POINT OF CARE INC.
Reel/Frame 017888/0795 →
Assignment of Assignor's Interest
Aug 31, 2006
From: NANOGEN POINT OF CARE INC.
To: NANOGEN INC.
Reel/Frame 018223/0537 →
Assignment of Intellectual Property Security Agreement
Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
Release of Security Interest
Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →